CAS |
No.30636-90-9 |
中文名称 |
原人参二醇 |
英文名称 |
(20S)-Protopanaxadiol |
别名 |
20(S-APPD);20-Epiprotopanaxadiol;20 (S-原人参二醇;(20S-Protopanaxadiol) |
分子式 |
C30H52O3 |
分子量 |
460.74 |
溶解性 |
Soluble in DMSO |
纯度 |
HPLC≥98% |
外观(性状) |
White to off-white Solid |
储存条件 |
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
MDL |
MFCD12032048 |
SMILES |
C[C@]([C@@](C[C@H]1O)([H])[C@]2(CC[C@@H]3O)C)(CC[C@@]2([H])C3(C)C)[C@]4([C@@]1([H])[C@]([C@@](C)(O)CC/C=C(C)/C)([H])CC4)C |
InChIKey |
PYXFVCFISTUSOO-HKUCOEKDSA-N |
InChI |
InChI=1S/C30H52O3/c1-19(2)10-9-14-30(8,33)20-11-16-29(7)25(20)21(31)18-23-27(5)15-13-24(32)26(3,4)22(27)12-17-28(23,29)6/h10,20-25,31-33H,9,11-18H2,1-8H3/t20-,21+,22-,23+,24-,25-,27-,28+,29+,30-/m0/s1 |
PubChem CID |
11213350 |
靶点 |
P-gp(P-glycoprotein);Apoptosis |
通路 |
Membrane Transporter&Ion Channel |
背景说明 |
是protopanaxadiol型人参皂苷的糖苷配基代谢衍生物,为凋亡诱导剂。 |
生物活性 |
20S-protopapanaxadiol (aglycone PPD, aPPD) , unlike its precursor ginsenosides Rg3 and Rh2, is not a substrate of P-gp. It is also the first time that aPPD has showed a reversible nature of its P-gp inhibition. In addition to its pro-apoptotic nature, aPPD may be a potential new P-gp inhibitor for cancer treatment.[1] |
In Vitro |
20S-protopapanaxadiol(aglycone PPD,aPPD)caused similar cytotoxicity in P388adr cells as their parental non-MDR cells,suggesting that aPPD may not be a substrate of P-gp. On the other hand,the calcein AM efflux assay showed that aPPD was able to inhibit P-gp activity as potently as verapamil on MDR cells. The blockage of P-gp activity was highly reversible as wash-out of aPPD resulted in an immediate recovery of P-gp activity. Unlike verapamil,aPPD did not affect ATPase activity of P-gp suggesting a different mechanism of action.[1] |
数据来源文献 |
[1]. Zhao Y, Bu L, Yan H, Jia W. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells. Planta Med. 2009 Aug;75(10):1124-8. |
规格 |
10mg 20mg |
单位 |
瓶 |